4-PYRIDONE DERIVATIVE COMPOUNDS AND USES THEREOF AS HIV INTEGRASE INHIBITORS
申请人:Merck Sharp & Dohme Corp.
公开号:EP2986291B1
公开(公告)日:2020-05-27
US9493479B2
申请人:——
公开号:US9493479B2
公开(公告)日:2016-11-15
[EN] 4-PYRIDONE DERIVATIVE COMPOUNDS AND USES THEREOF AS HIV INTEGRASE INHIBITORS<br/>[FR] COMPOSÉS DÉRIVÉS DE 4-PYRIDONE ET LEURS UTILISATIONS EN TANT QU'INHIBITEURS DE LA VIH INTÉGRASE
申请人:MERCK SHARP & DOHME
公开号:WO2014172188A2
公开(公告)日:2014-10-23
The present invention relates to 4-Pyridone Compounds of Formula (I); and pharmaceutically acceptable salts and prodrugs thereof, wherein A, R1, R2, and R3 are as defined herein. The present invention also relates to compositions comprising at least one 4-Pyridone Compound, and methods of using the 4-Pyridone Compounds for treating or preventing HIV infection in a subject or the clinical manifestations thereof.
[EN] STEREOSPECIFIC PROCESS FOR 3-HETEROCYCLYLCYCLOALIPHATIC-1,2-DIOLS<br/>[FR] PROCÉDÉ STÉRÉOSPÉCIFIQUE POUR DIOLS 3-HETEROCYCLYLCYCLOALIPHATIQUES-1,2
申请人:ICAHN SCHOOL OF MEDECINE AT MOUNT SINAI
公开号:WO2017024229A1
公开(公告)日:2017-02-09
A process for the stereoselective synthesis of chiral 3-heterocyclyl-1,2-dihydroxy cyclohexanes is disclosed. The process involves reacting a tricyclic nitrogenous heterocycle with an allyl carbonate in the presence of a chiral palladium catalyst followed by oxidation of the olefinic bond to provide 3-heterocyclyl-1,2-dihydroxy cyclohexanes, cyclopentanes and corresponding alicyclic heterocycles. Also disclosed are methods for converting the heterocyclyl-1,2-dihydroxy cyclohexanes to 2-amino-6-(heteroaryl)cyclohexanols (and related cyclic compounds).
Use of pyridinium chlorochromate as methylene oxidant in 5,6-dihydropyrans: a practical one-step preparation of the anhydromevalonolactone
作者:Francesco Bonadies、Romano Di Fabio、Carlo Bonini